These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35418450)

  • 21. Long-term safety and effectiveness of stiripentol in patients with Dravet syndrome: Interim report of a post-marketing surveillance study in Japan.
    Yamada M; Suzuki K; Matsui D; Inoue Y; Ohtsuka Y
    Epilepsy Res; 2021 Feb; 170():106535. PubMed ID: 33388609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growth.
    Gil-Nagel A; Sullivan J; Ceulemans B; Wirrell E; Devinsky O; Nabbout R; Knupp KG; Scott Perry M; Polster T; Davis R; Lock M; Cortes RM; Gammaiton AR; Farfel G; Galer BS; Agarwal A
    Epilepsy Behav; 2021 Sep; 122():108212. PubMed ID: 34352670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ataluren for drug-resistant epilepsy in nonsense variant-mediated Dravet syndrome and CDKL5 deficiency disorder.
    Devinsky O; King L; Bluvstein J; Friedman D
    Ann Clin Transl Neurol; 2021 Mar; 8(3):639-644. PubMed ID: 33538404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical, economic, and humanistic burden of Dravet syndrome - A systematic literature review.
    Sullivan J; Deighton AM; Vila MC; Szabo SM; Maru B; Gofshteyn JS; James ES; Rico S; Zuberi SM
    Epilepsy Behav; 2022 May; 130():108661. PubMed ID: 35334258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy.
    Nabbout R; Chemaly N; Chipaux M; Barcia G; Bouis C; Dubouch C; Leunen D; Jambaqué I; Dulac O; Dellatolas G; Chiron C
    Orphanet J Rare Dis; 2013 Nov; 8():176. PubMed ID: 24225340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dravet syndrome with parkinsonian symptoms and intact dopaminergic neurons: A case report.
    Kanatani M; Adachi T; Sakata R; Nishimura Y; Saito Y; Maegaki Y; Watanabe Y; Hanajima R
    Brain Dev; 2021 Mar; 43(3):486-489. PubMed ID: 33199159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of focal gray matter atrophy are associated with bradykinesia and gait disturbances in older adults.
    Rosano C; Bennett DA; Newman AB; Venkatraman V; Yaffe K; Harris T; Kritchevsky S; Aizenstein HJ
    J Gerontol A Biol Sci Med Sci; 2012 Sep; 67(9):957-62. PubMed ID: 22367436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidities and predictors of health-related quality of life in Dravet syndrome.
    Brunklaus A; Dorris L; Zuberi SM
    Epilepsia; 2011 Aug; 52(8):1476-82. PubMed ID: 21668444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative Characterization of Motor Control during Gait in Dravet Syndrome Using Wearable Sensors: A Preliminary Study.
    Bisi MC; Di Marco R; Ragona F; Darra F; Vecchi M; Masiero S; Del Felice A; Stagni R
    Sensors (Basel); 2022 Mar; 22(6):. PubMed ID: 35336311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mechanics behind gait problems in patients with Dravet Syndrome.
    Wyers L; Verheyen K; Ceulemans B; Schoonjans AS; Desloovere K; Van de Walle P; Hallemans A
    Gait Posture; 2021 Feb; 84():321-328. PubMed ID: 33445141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dravet syndrome: Characteristics, comorbidities, and caregiver concerns.
    Villas N; Meskis MA; Goodliffe S
    Epilepsy Behav; 2017 Sep; 74():81-86. PubMed ID: 28732259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Amimia in Parkinson's disease. Significance and correlation with the clinical features].
    Garcia-Ruiz PJ; Feliz-Feliz CE; Maycas-Cepeda T; Del Val-Fernandez J
    Rev Neurol; 2018 Jan; 66(2):45-48. PubMed ID: 29323400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of seizure frequency on quality of life in patients with Lennox-Gastaut syndrome or Dravet syndrome.
    Auvin S; Damera V; Martin M; Holland R; Simontacchi K; Saich A
    Epilepsy Behav; 2021 Oct; 123():108239. PubMed ID: 34375802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The direct and indirect costs of Dravet Syndrome.
    Whittington MD; Knupp KG; Vanderveen G; Kim C; Gammaitoni A; Campbell JD
    Epilepsy Behav; 2018 Mar; 80():109-113. PubMed ID: 29414539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unilateral versus bilateral tasks in early asymmetric Parkinson's disease: differential effects on bradykinesia.
    Kishore A; Espay AJ; Marras C; Al-Khairalla T; Arenovich T; Asante A; Miyasaki J; Lang AE
    Mov Disord; 2007 Feb; 22(3):328-33. PubMed ID: 17216641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dravet syndrome in children-A population-based study.
    Bjurulf B; Reilly C; Sigurdsson GV; Thunström S; Kolbjer S; Hallböök T
    Epilepsy Res; 2022 May; 182():106922. PubMed ID: 35461153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany.
    Strzelczyk A; Pringsheim M; Mayer T; Polster T; Klotz KA; Muhle H; Alber M; Trollmann R; Spors H; Kluger G; Kurlemann G; Schubert-Bast S
    Epilepsia; 2021 Oct; 62(10):2518-2527. PubMed ID: 34378197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Objective Assessment of Bradykinesia Estimated from the Wrist Extension in Older Adults and Patients with Parkinson's Disease.
    Rabelo AG; Neves LP; Paixão APS; Oliveira FHM; de Souza LAPS; Vieira MF; Pereira AA; Andrade AO
    Ann Biomed Eng; 2017 Nov; 45(11):2614-2625. PubMed ID: 28852889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contributions of mild parkinsonian signs to gait performance in the elderly.
    Allali G; Verghese J; Mahoney JR
    Age (Dordr); 2014; 36(4):9678. PubMed ID: 24981115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Instrumented gait analysis of patients with Dravet syndrome.
    Mileti I
    Eur J Paediatr Neurol; 2019 Nov; 23(6):763. PubMed ID: 31679959
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.